Hemostemix Welcomes Shaune Harding, OStJ, RN as Director of Patient Care & Clinical Operations

Core Insights - Hemostemix Inc. has appointed Shaune Harding as the Director of Patient Care & Clinical Operations, enhancing its patient-centric healthcare model [1][2][3] Company Overview - Hemostemix is a leader in autologous stem cell therapeutics, particularly for ischemic diseases, and has been operational since 2003 [4] - The company has developed and patented VesCell™ (ACP-01), a blood-based stem cell therapy, and has completed seven clinical studies involving 318 subjects [4] - Hemostemix has published results in eleven peer-reviewed publications, demonstrating the safety and clinical relevance of ACP-01 for various ischemic conditions [4] Appointment of Shaune Harding - Shaune Harding brings over 30 years of clinical and management experience, which will be utilized to improve the personalized care experience in The Bahamas, Florida, and Canada [2] - Her role will ensure long-term continuity of care for patients treated with VesCell and facilitate the capture of patient data for regulatory approval of ACP-01 [2] Patient Care Operations - The responsibilities of the new Director include onboarding new patients, reviewing medical records, and mapping patient health journeys from assessment to multi-year follow-up [6] - Continuous monitoring of patient data will be conducted, including metrics on heart rate, activity, and sleep, using approved wearable devices [6] - Monthly follow-up meetings will support goal setting and adherence to healthcare journeys, along with adverse event monitoring and compliance with regulatory obligations [6]